https://www.pharmacytimes.com/view/bepirovirsen-reduces-levels-of-hepatitis-b-surface-antigen-hepatitis-b-virus-dna
0
0
8/8/22 at 1:00pm
Organization
Pharmacytimes.com
The B-Clear study investigated the efficacy and safety of 12- or 24-weeks treatment with bepirovirsen in individuals with chronic hepatitis B.
Create an account
or login to join the discussion